Trio Grup

Executive Summary

Trio Grup is a Turkish contract research organization (CRO) founded in 2010 that provides clinical trial management, monitoring, and consulting services to domestic and international pharmaceutical companies, research institutions, and healthcare organizations. With a focus on small molecules and drug delivery, the company has established itself as a leading CRO in Turkey, offering end-to-end support for clinical research projects. Despite limited public financial data, Trio Grup's private status and specialized service model position it within the growing global CRO market, which benefits from increasing R&D outsourcing by pharma firms. The company's competitive edge lies in its local expertise, regulatory knowledge, and ability to manage complex trials across Europe and emerging markets. However, its scale remains modest compared to global CROs, and revenue growth is tied to client acquisition and project pipeline expansion.

Upcoming Catalysts (preview)

• Q3 2026New multi-year contract with a top-20 pharma company for Phase III oncology trial management60% success
• Q4 2026Expansion into Central & Eastern European markets via a strategic partnership or subsidiary55% success
• Q2 2026Obtaining ISO 27001 certification for data security, enabling larger international contracts80% success